# Increasing awareness and knowledge of Alpha-gal Syndrome in the United States

Source: https://welltoldgrants.com/grants/cdc-rfa-ck-26-0193-increasing-awareness-and-knowledge-of-alpha-gal-syndrome/  
Official notice: https://www.grants.gov/search-results-detail/360958

> Centers for Disease Control - NCEZID offered grants of up to $1.0 million (at least $25,000) to any type of organization. It expected to make about 3 awards worth $10.0 million in total. Applications closed on July 9, 2026.

| Field | Value |
|---|---|
| Opportunity number | CDC-RFA-CK-26-0193 |
| Agency | Centers for Disease Control - NCEZID |
| Status | Forecast |
| Deadline | July 9, 2026 |
| Award ceiling | $1.0 million |
| Award floor | $25,000 |
| Expected awards | 3 |
| Total funding | $10.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.084 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2

## What the grant funds

The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of a network of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response. 2) EDUCATE - Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, outdoor workers, etc.). Create communications targeted at healthcare providers including educational resources and training. 3) TRACK - Conduct active or enhances public health surveillance for AGS. This strategy could involve patient populations or geographical locations with limited access to specialized healthcare provider care.

## Questions people ask

### Is CDC-RFA-CK-26-0193 still open?

No. It closed on July 9, 2026. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

### Who can apply for Increasing awareness and knowledge of Alpha-gal Syndrome in the United States?

Centers for Disease Control - NCEZID accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Increasing awareness and knowledge of Alpha-gal Syndrome in the United States?

Closed July 9, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.0 million each. About $10.0 million in total across about 3 awards.

### Who has won Prevention of Disease, Disability, and Death by Infectious Diseases   grants before?

The largest recipients over five fiscal years were Puerto Rico Science, Technology, and Research Trust, Massachusetts Department of Public Health, Emory University. The program made 128 awards worth $241 million in that time.